Drug trials set stage for marketing war
Two major studies of experimental clot-busting drugs from Genetech Inc. and Bristol-Myers Squibb Corp. have set the stage for a marketing war for the successor to Genetech's heart attack treatment,
Two major studies of experimental clot-busting drugs from Genetech Inc. and Bristol-Myers Squibb Corp. have set the stage for a marketing war for the successor to Genetech's heart attack treatment,